Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    January 2018
  1. BOUSIGES O, Bombois S, Schraen S, Wallon D, et al
    Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316385.
    PubMed     Text format     Abstract available


    December 2017
  2. SOUSA ALVES G
    CSF beta-amyloid and white matter damage: unravelling the neuropathology of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317053.
    PubMed     Text format    


  3. KING E, O'Brien JT, Donaghy P, Morris C, et al
    Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias.
    J Neurol Neurosurg Psychiatry. 2017 Dec 16. pii: jnnp-2017-317134.
    PubMed     Text format     Abstract available


  4. CONNOR JR
    CSF ferritin predicts CSF Abeta decline in biomarker-determined Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-317050.
    PubMed     Text format    


  5. BROWN JM, Lansdall CJ, Wiggins J, Dawson KE, et al
    The Test Your Memory for Mild Cognitive Impairment (TYM-MCI).
    J Neurol Neurosurg Psychiatry. 2017;88:1045-1051.
    PubMed     Text format     Abstract available


    November 2017
  6. BANERJEE G, Carare R, Cordonnier C, Greenberg SM, et al
    The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.
    J Neurol Neurosurg Psychiatry. 2017;88:982-994.
    PubMed     Text format     Abstract available


  7. HARPER L, Bouwman F, Burton EJ, Barkhof F, et al
    Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.
    J Neurol Neurosurg Psychiatry. 2017;88:908-916.
    PubMed     Text format     Abstract available


    October 2017
  8. PIETROBONI AM, Scarioni M, Carandini T, Basilico P, et al
    CSF beta-amyloid and white matter damage: a new perspective on Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2017 Oct 20. pii: jnnp-2017-316603.
    PubMed     Text format     Abstract available


    September 2017
  9. AYTON S, Diouf I, Bush AI
    Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study.
    J Neurol Neurosurg Psychiatry. 2017 Sep 22. pii: jnnp-2017-316551.
    PubMed     Text format     Abstract available


  10. DARBY RR, Brickhouse M, Wolk DA, Dickerson BC, et al
    Effects of cognitive reserve depend on executive and semantic demands of the task.
    J Neurol Neurosurg Psychiatry. 2017;88:794-802.
    PubMed     Text format     Abstract available


    August 2017
  11. LAI KSP, Liu CS, Rau A, Lanctot KL, et al
    Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.
    J Neurol Neurosurg Psychiatry. 2017 Aug 9. pii: jnnp-2017-316201.
    PubMed     Text format     Abstract available


    July 2017
  12. MCKIERNAN EF, O'Brien JT
    7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature.
    J Neurol Neurosurg Psychiatry. 2017;88:564-574.
    PubMed     Text format     Abstract available


    March 2017
  13. WOODHEAD ZV, Crinion J, Teki S, Penny W, et al
    Auditory training changes temporal lobe connectivity in 'Wernicke's aphasia': a randomised trial.
    J Neurol Neurosurg Psychiatry. 2017 Mar 4. pii: jnnp-2016-314621.
    PubMed     Text format     Abstract available


    February 2017
  14. PRESSMAN PS, Simpson M, Gola K, Shdo SM, et al
    Observing conversational laughter in frontotemporal dementia.
    J Neurol Neurosurg Psychiatry. 2017 Feb 24. pii: jnnp-2016-314931.
    PubMed     Text format     Abstract available


  15. LEMSTRA AW, de Beer MH, Teunissen CE, Schreuder C, et al
    Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry. 2017;88:113-118.
    PubMed     Text format     Abstract available


    November 2016
  16. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    PubMed     Text format     Abstract available


  17. AHMED S, Baker I, Thompson S, Husain M, et al
    Utility of testing for apraxia and associated features in dementia.
    J Neurol Neurosurg Psychiatry. 2016;87:1158-1162.
    PubMed     Text format     Abstract available


    August 2016
  18. MENENDEZ-GONZALEZ M
    Association between naturally occurring antiamyloid beta autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2016 Aug 2. pii: jnnp-2016-314136.
    PubMed     Text format    


    June 2016
  19. KIMURA A, Takemura M, Saito K, Yoshikura N, et al
    Association between naturally occurring anti-amyloid beta autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2016 Jun 21. pii: jnnp-2016-313476.
    PubMed     Text format     Abstract available


    April 2016
  20. MIRZA SS, de Bruijn RF, Koudstaal PJ, van den Meiracker AH, et al
    The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population.
    J Neurol Neurosurg Psychiatry. 2016;87:356-62.
    PubMed     Text format     Abstract available


    March 2016
  21. WANG J, Logovinsky V, Hendrix SB, Stanworth SH, et al
    ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials.
    J Neurol Neurosurg Psychiatry. 2016 Mar 23. pii: jnnp-2015-312383.
    PubMed     Text format     Abstract available


    January 2016
  22. MATTSSON N, Schott JM, Hardy J, Turner MR, et al
    Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2016 Jan 8. pii: jnnp-2015-311321.
    PubMed     Text format     Abstract available


  23. STEFANIAK J, O'Brien J
    Imaging of neuroinflammation in dementia: a review.
    J Neurol Neurosurg Psychiatry. 2016;87:21-8.
    PubMed     Text format     Abstract available


    December 2015
  24. LAAKSO MP, Jukarainen NM, Vepsalainen J
    Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid.
    J Neurol Neurosurg Psychiatry. 2015;86:1286-90.
    PubMed     Text format     Abstract available


    September 2015
  25. LESLIE FV, Foxe D, Daveson N, Flannagan E, et al
    FRONTIER Executive Screen: a brief executive battery to differentiate frontotemporal dementia and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2015 Sep 29. pii: jnnp-2015-311917.
    PubMed     Text format     Abstract available


  26. KILE S, Au W, Parise C, Rose K, et al
    IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    J Neurol Neurosurg Psychiatry. 2015 Sep 29. pii: jnnp-2015-311486.
    PubMed     Text format     Abstract available


    August 2015
  27. XU W, Tan L, Wang HF, Jiang T, et al
    Meta-analysis of modifiable risk factors for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2015 Aug 20. pii: jnnp-2015-310548.
    PubMed     Text format     Abstract available


    July 2015
  28. BERTOUX M, Hornberger M
    'Try to see it my way': which theory of mind tests best distinguish bvFTD and AD?
    J Neurol Neurosurg Psychiatry. 2015;86:706.
    PubMed     Text format    


    June 2015
  29. WARLOW C
    Driving safely with dementia.
    J Neurol Neurosurg Psychiatry. 2015;86:593-4.
    PubMed     Text format    


  30. BROWN J
    The use and misuse of short cognitive tests in the diagnosis of dementia.
    J Neurol Neurosurg Psychiatry. 2015;86:680-5.
    PubMed     Text format     Abstract available


    May 2015
  31. LI JQ, Tan L, Wang HF, Tan MS, et al
    Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies.
    J Neurol Neurosurg Psychiatry. 2015 May 22. pii: jnnp-2014-310095.
    PubMed     Text format     Abstract available


    March 2015
  32. HALLIDAY G
    Progressive supranuclear palsy finally has a clinically measureable tau abnormality.
    J Neurol Neurosurg Psychiatry. 2015;86:241.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: